Dental Computed Tomography X-ray System (Rubik XSmart, Rubik X1, Rubik X3) (Matrix 7000, Matrix 7800)
Fussen Technology Co., Ltd. · Decision date Sep 30, 2026
What did the FDA decide?
FDA recorded a substantially equivalent (SESE) decision on September 30, 2026 for K263033, a premarket notification submitted by Fussen Technology Co., Ltd. of Shenzhen, China, received August 31, 2026. The device is a Dental Computed Tomography X-ray System under 21 CFR 892.1750, Class II, product code OAS, in the Radiology panel. The listed trade names are Rubik XSmart, Rubik X1 and Rubik X3, with models Matrix 7000 and Matrix 7800.
The submission describes a system producing cone-beam computed tomography, panoramic tomography and optional cephalometric images for diagnostic use in oral and maxillofacial regions, operated by trained professionals under physician guidance. The summary names K251842 as the predicate, also from Fussen, and reports the same indications, similar structure and comparable field-of-view, scan-time and software characteristics. The summary states no clinical study was included. SESE means clearance to market, not PMA approval; the record does not disclose performance test results or the basis for the Matrix 7000 configuration differences.
- Regulatory pathway
- 510(k) premarket notification
- Clinical specialty
- Radiology
- Decision date
- Sep 30, 2026
FDA source record · MedtechLedger’s explanation describes the recorded change.
Regulatory record facts
- Identifier
- K263033
- Regulatory pathway
- 510(k) premarket notification
- Applicant
- Fussen Technology Co., Ltd.
- Product code
- OAS
- Decision code
- SESE
- Decision date
- Sep 30, 2026
- Source update
- Nov 9, 2026
- Original record
- Open FDA source record
About this medical device
FDA device category: X-Ray, Tomography, Computed, Dental.
- Applicant
- Fussen Technology Co., Ltd.
- Product code
- OAS
- FDA device class
- 2
FDA decision timeline
K263033 received
Application receipt date recorded by FDA.
K263033 · FDA decision
SESE
Related devices and submissions
Explore the linked device profile
No additional submissions with a verified PMA or product-code relationship are linked here.
Regulatory context
A 510(k) submission seeks a finding of substantial equivalence to a legally marketed device. A clearance and a PMA approval are different regulatory decisions.
Read our guide to FDA clearance and approval · FDA’s explanation of this pathway
Manufacturer intelligence
Fussen Technology Co., Ltd.
- Headquarters
- Not reported
- Brand website
- Not reported
- FDA applicant address
- Shenzhen
Sources and methodology
- Original FDA record: K263033
- openFDA source data · Source release Nov 9, 2026 · Retrieved Nov 19, 2026
FDA fields and approval-order wording are presented as source information. MedtechLedger explanations are identified separately and describe the scope of the recorded decision. Indications from an original PMA are historical unless confirmed against subsequent labeling and supplements.
How we use FDA records